Atorvastatin Calcium
Product Images NDC 60760-558

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

558-30 (Atorvastation 60760 558 30)

Label for atorvastatin calcium tablets, USP 40 mg, quantity 30. Manufactured by Graviti Pharmaceuticals Pvt. Ltd., Telangana, India. Packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. Includes placeholder text for lot number, expiration, and prescription number, with storage instructions to keep at controlled room temperature between 15°-30°C (59°-86°F).*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 01)

Chemical structure diagram of atorvastatin calcium, showing the detailed molecular composition including aromatic rings, fluorine atom, and calcium ion complexation with water molecules. This diagram represents the active ingredient atorvastatin calcium as depicted in the product data.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 02)

A line chart showing cumulative incidence percentage over 3.5 years comparing Atorvastatin and placebo groups. The solid line represents Atorvastatin with lower incidence, and the dotted line represents placebo with higher incidence. The graph includes hazard ratio (HR=0.64) and p-value (0.0005).*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 03)

A line graph showing cumulative hazard percentage over a 5-year follow-up period, comparing placebo and atorvastatin groups. The x-axis represents time to first primary endpoint in years, and the y-axis shows cumulative hazard in percentage. The graph includes a hazard ratio (HR) of 0.63 with a confidence interval of 0.48 to 0.83 and a p-value of 0.001.*

FDA Label Image

Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 04)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time for atorvastatin 10 mg and 80 mg doses. The x-axis represents years to first major cardiovascular endpoint (0 to 5 years), and the y-axis shows the percentage of subjects. The graph includes hazard ratio (HR 0.78) and p-value (0.0002) indicating statistical analysis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.